IP Library Granted Patent US 9,133,431
Granted Patent B2
US 9,133,431 · App. 12/771,985 · Granted Sep 15, 2015

Systems, methods and compositions for optimizing tissue and cell enriched grafts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,133,431
App. No.
12/771,985
Granted
Sep 15, 2015
Kind
B2
Abstract

Disclosed herein are methods and systems for the concentration of cells from a cell suspension into unprocessed tissue, such as adipose tissue. Also disclosed herein are systems for optimizing hydration of tissue and cell enriched grafts.

Claims (30)

1. An adipose tissue processing device, comprising: a flexible, collapsible bag comprising a first outer shell and a second outer shell that are joined to form a bag, wherein the bag comprises:

a first port in communication with a first subsystem, which receives adipose tissue and, which is defined by a first outer shell of the bag and a filter disposed within the bag, wherein the filter comprises a plurality of pores that pass liquids, tumescent fluids, red blood cells, and wash solutions and retain mature adipocytes, regenerative cells, stem cells, progenitor cells and connective tissue; and

a second port in communication with a second subsystem, which is defined by the filter and the second outer shell of the bag,

wherein the second subsystem further comprises a separator that creates a space between the filter and the second outer shell of the bag,

wherein said separator comprises a separation screen or mesh that comprises pores that are larger than the pores in the filter,

wherein the first subsystem and second subsystem are configured to store tissue or cell samples within the bag as the flexible, collapsible bag expands, wherein the pore size of said filter is between about 30 μm and about 200 μm, and

wherein the separator comprises pores that comprise a pore size that is between about 300 and 2000 μm.

2. The adipose tissue processing device of claim 1 , wherein the separator has a degree of freedom.

3. The adipose tissue processing device of claim 1 , wherein the separator is free floating within said second subsystem.

4. The adipose tissue processing device of claim 1 , wherein the separator comprises on or more ribs.

5. The adipose tissue processing device of claim 1 , wherein the separator comprises on or more struts.

6. The adipose tissue processing device of claim 1 , wherein the first outer shell and the second outer shell are joined by a double heat seal.

7. The adipose tissue processing device of claim 6 , wherein the filter is joined to the first outer shell and the second outer shell by a double heat seal.

8. The adipose tissue processing device of claim 1 , wherein said separator comprises a mesh.

9. The adipose tissue processing device of claim 1 , wherein said separator comprises a screen.

10. The adipose tissue processing device of claim 1 , wherein said first port is configured to releasably connect with an adapter, said adapter being configured to releasably connect with a syringe barrel.

11. The adipose tissue processing device of claim 10 , wherein the first port is configured to allow material to enter into the first port, but not to exit from the first port.

12. The adipose tissue processing device of claim 11 , wherein said first port comprises a deformable plastic valve.

13. The adipose tissue processing device of claim 10 , wherein the syringe barrel is a 60 mL catheter syringe barrel.

14. The adipose tissue processing device of claim 1 , wherein the first port is configured to be attached to a cannula, while maintaining a sterile fluid/tissue pathway.

15. The adipose tissue processing device of claim 1 , further comprising a third port in communication with the first subsystem, which exists between the first outer shell of the bag and the filter disposed within the bag.

16. The adipose tissue processing device of claim 15 , wherein said third port is connected to a Y connector.

17. A method of making an adipose tissue graft, comprising:

(a) obtaining a first portion of unprocessed adipose tissue;

(b) introducing said first portion of unprocessed adipose tissue into the first subsystem of a first device of claim 1 ,

(c) rinsing the first portion of unprocessed adipose tissue by adding a physiologic wash solution to the first subsystem; and

(d) removing fluid from the second subsystem of the first device, wherein the fluid is selected from the group consisting of water, physiologic wash solution, blood and free lipid, or any combination thereof, thereby dehydrating the adipose tissue.

18. The method of claim 17 , wherein the physiologic wash solution is selected from the group consisting of Lactated Ringer's solution, Hartmann's Solution, and saline.

19. The method of claim 17 , wherein said dehydrated adipose tissue has a liquid content that is less than about ½, ⅓, or ¼ times that of said first portion of unprocessed adipose tissue prior to the introducing step.

20. The method of claim 17 , wherein said dehydrated adipose tissue has a liquid content that is less than about ⅓ that of said first portion of unprocessed adipose tissue prior to the introducing step.

Assignments (15)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2019
From: BIMINI TECHNOLOGIES LLC
To: PUREGRAFT LLC
Reel/Frame 050888/0878 →
CONDITIONAL ASSIGNMENT Recorded Oct 29, 2019
From: CYTORI THERAPEUTICS, INC.
To: BIMINI TECHNOLOGIES LLC
Reel/Frame 050852/0910 →
CONFIRMATORY ASSIGNMENT Recorded Oct 14, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 050724/0450 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY NAME PREVIOUSLY RECORDED AT REEL: 48861 FRAME: 926. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 24, 2019
From: BIMINI TECHNOLOGIES LLC
To: PUREGRAFT LLC
Reel/Frame 050481/0043 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECT ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED AT REEL: 049313 FRAME: 0434. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 1, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049942/0204 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049313/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2019
From: CYTORI THERAPEUTICS, INC.
To: LOREM VASCULAR PTE. LTD.
Reel/Frame 049651/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2019
From: OXFORD FINANCE LLC
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 049011/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2019
From: BIMINI TECHNOLOGY LLC
To: PUREGRAFT LLC
Reel/Frame 048861/0926 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2015
From: OXFORD FINANCE LLC
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 035902/0191 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2014
From: CYTORI THERAPEUTICS, INC.
To: BIMINI TECHNOLOGIES LLC
Reel/Frame 033715/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2013
From: CYTORI THERAPEUTICS, INC.
To: PUREGRAFT LLC
Reel/Frame 031482/0815 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2013
From: CYTORI THERAPEUTICS, INC.
To: PUREGRAFT LLC
Reel/Frame 031174/0029 →
RELEASE OF SECURITY INTEREST Recorded Jul 3, 2013
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: CYTORI THERAPEUTICS, INC.
Reel/Frame 030734/0778 →
SECURITY AGREEMENT Recorded Jun 28, 2013
From: CYTORI THERAPEUTICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 030715/0625 →